Overview
Product name | Recombinant Human LR3-IGF-1(E51R) Protein |
---|
Catalog No. | RP00825 |
---|
Description | Recombinant Human LR3-IGF-1(E51R) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Gly49-Ala118) of human IGF-1 (Accession #P05019) with the substitution of an Arg for Glu at position three and the addition of a thirteen aa N-terminal extension. |
---|
Purity | ≥ 95 % as determined by SDS-PAGE |
---|
Endotoxin | < 1 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
---|
Species | Human |
---|
Calculated MW | 9.12 kDa |
---|
Background
Long R3 IGF-1 (LR3 IGF-1) is a synthetic analog of IGF-1 that is generated by modifying the AA sequence for mature human IGF-1. These modifications include the substitution of an Arg for Glu at position three of the mature IGF-1 sequence and the addition of a thirteen aa N-terminal extension, which is derived from methionyl porcine Growth Hormone. These aa changes generate a protein that is still capable of binding to IGF-1 and Insulin receptors, but shows considerably lower affinity binding to IGFBPs compared to wild-type IGF-1. As a result, LR3 IGF-1 has an increased half-life and displays increased biological potency compared to IGF-1.
Product information
Synonym | IGF1; IBP1; IGF-1; Insulin-like growth factor 1; Insulin-like growth factor I; IGF-I; Mechano growth factor; MGF; Somatomedin-C |
---|
Expression Host | E. coli |
---|
Tag | NO-Tag |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.